BACKGROUND: Branched-chain amino acids (BCAAs: isoleucine, leucine, and valine) and aromatic amino acids (AAAs: phenylalanine and tyrosine) are hypothesized to influence early-life obesity risk. OBJECTIVE: To assess HM free amino acid (AA) concentrations and infant intakes of HM AAs from women with obesity (OB) compared to those with normal weight (NW) and determine the relationships between HM AA consumption and infant growth. METHODS: HM samples were collected at 0.5 (n = 151), 2 (n = 129), and 6 (n = 93) months postpartum from mothers with NW (body mass index [BMI] = 18.5-24.9 kg/m2 ) and OB (BMI > 30 kg/m2 ). HM AAs were quantified via mass spectrometry. Infant HM intake, anthropometrics and body composition were assessed. Linear mixed-effects models (LMEM) examined the relationships between maternal BMI and HM AA intakes, and HM AA intake and infant growth over the first 6 months postpartum after adjusting for maternal and infant characteristics. RESULTS: Maternal BMI was positively associated with infant intakes of isoleucine, leucine, and AAAs across timepoints. HM AA intakes were positively associated with weight-for-length z-score, fat mass index, and fat-free mass index in infants (p < 0.05). CONCLUSIONS: Maternal BMI led to differences in HM AA composition, which was associated with infant body composition.
BACKGROUND: Branched-chain amino acids (BCAAs: isoleucine, leucine, and valine) and aromatic amino acids (AAAs: phenylalanine and tyrosine) are hypothesized to influence early-life obesity risk. OBJECTIVE: To assess HM free amino acid (AA) concentrations and infant intakes of HM AAs from women with obesity (OB) compared to those with normal weight (NW) and determine the relationships between HM AA consumption and infant growth. METHODS: HM samples were collected at 0.5 (n = 151), 2 (n = 129), and 6 (n = 93) months postpartum from mothers with NW (body mass index [BMI] = 18.5-24.9 kg/m2 ) and OB (BMI > 30 kg/m2 ). HM AAs were quantified via mass spectrometry. Infant HM intake, anthropometrics and body composition were assessed. Linear mixed-effects models (LMEM) examined the relationships between maternal BMI and HM AA intakes, and HM AA intake and infant growth over the first 6 months postpartum after adjusting for maternal and infant characteristics. RESULTS: Maternal BMI was positively associated with infant intakes of isoleucine, leucine, and AAAs across timepoints. HM AA intakes were positively associated with weight-for-length z-score, fat mass index, and fat-free mass index in infants (p < 0.05). CONCLUSIONS: Maternal BMI led to differences in HM AA composition, which was associated with infant body composition.
Authors: Ann R Spevacek; Jennifer T Smilowitz; Elizabeth L Chin; Mark A Underwood; J Bruce German; Carolyn M Slupsky Journal: J Nutr Date: 2015-06-03 Impact factor: 4.798
Authors: Stefan A Czerwinski; Miryoung Lee; Audrey C Choh; Keith Wurzbacher; Ellen W Demerath; Bradford Towne; Roger M Siervogel Journal: Am J Hum Biol Date: 2007 Sep-Oct Impact factor: 1.937
Authors: Peter Rzehak; Christian Hellmuth; Olaf Uhl; Franca F Kirchberg; Wolfgang Peissner; Ulrike Harder; Veit Grote; Martina Weber; Annick Xhonneux; Jean-Paul Langhendries; Natalia Ferre; Ricardo Closa-Monasterolo; Elvira Verduci; Enrica Riva; Piotr Socha; Dariusz Gruszfeld; Berthold Koletzko Journal: Ann Nutr Metab Date: 2014-10-02 Impact factor: 3.374
Authors: Rebecca A Krukowski; Delia S West; Marisha DiCarlo; Kartik Shankar; Mario A Cleves; Marie E Saylors; Aline Andres Journal: BMC Pregnancy Childbirth Date: 2016-11-21 Impact factor: 3.007